KONINKLIJKE PHILIPS NV【PHG】

時価総額

PER

医療機器・ヘルステクノロジーの最大手。AI搭載の画像診断・生体モニタリングや個人向け健康製品を展開。長期投資家のExorが2023年8月に15%出資、2024年6月に17.51%に増加。北米・欧州・中国を中心に73%を占める展開地域。

	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Profit (loss)	1,870	1,097	1,173	1,195	3,323	-1,605	-463	-698
Discontinued operations, net of income taxes	843	-213	-19	-10	2,711	13	-10	142
Depreciation, amortization, and impairment of assets	-	-	-	-	-	1,602	1,261	1,390
Impairment of goodwill	-	-	-	-	-	1,357	8	-
Share-based compensation	-	-	98	115	108	95	88	96
Net loss (gain) on sale of assets	-107	-71	77	2	-55	-115	-71	-19
Interest income	-40	-31	27	14	18	25	46	81
Adjustments for interest expense	186	165	174	160	152	226	255	270
Investments in associates, net of income taxes	-	-	-	-	-	112	-107	-126
Income tax expense (benefit)	349	193	337	284	-103	-113	-71	964
Decrease (increase) in working capital	-101	179	819	87	401	862	-913	355
Decrease (increase) in receivables and other current assets	64	-97	-274	87	-39	-342	298	-1
Decrease (Increase) in inventories	-144	-394	-175	-584	-581	-572	257	230
Increase (decrease) in accounts payable, accrued and other current liabilities	181	311	-369	411	219	52	358	-583
Decrease (increase) in non-current receivables and other assets	-	-	-	-	-	1	33	5
Increase (decrease) in other liabilities	-	-	-	-	-	-84	-38	-51
Adjustments for provisions	-252	-271	27	-87	427	-199	422	316
Other items	377	37	-5	13	-164	-39	129	101
Interest received	40	35	27	15	17	15	53	83
Interest paid	215	170	172	148	151	205	250	261
Dividends received from investments in associates	6	20	12	4	14	12	13	8
Income taxes paid	-284	-301	363	394	249	333	152	173
Net cash provided by (used for) operating activities	1,870	1,780	2,031	2,777	1,629	-173	2,136	1,569
Net capital expenditures	-685	-796	978	924	729	788	554	663
Purchase of intangible assets	-106	-123	156	127	107	105	96	118
Expenditures on development assets	-333	-298	339	302	259	257	203	241
Capital expenditures on property, plant and equipment	-420	-422	518	513	397	444	345	317
Proceeds from sales of property, plant and equipment	175	46	35	18	33	18	90	13
Net proceeds from (cash used for) derivatives and current financial assets	-198	-175	385	-13	48	-72	-46	38
Purchase of other non-current financial assets	-42	-34	63	131	124	116	92	123
Proceeds from other non-current financial assets	6	77	162	65	124	78	48	57
Purchase of businesses, net of cash acquired	-2,344	-628	255	317	3,098	712	73	8
Net proceeds from sale of interests in businesses, net of cash disposed	64	70	146	4	107	124	80	126
Net cash provided by (used for) for investing activities	-3,199	-1,486	-603	-1,316	-3,672	-1,487	-636	-573
Proceeds from issuance (payments on) short-term debt	12	34	23	16	-25	47	29	-30
Principal payments on current portion of long-term debt	-1,332	-1,161	761	298	302	1,472	754	763
Proceeds from issuance of long-term debt	1,115	1,287	847	1,065	76	2,516	544	710
Re-issuance of treasury shares	-	-	-	-	-	12	-	-
Purchase of treasury shares	-642	-1,042	1,376	343	1,636	187	662	411
Dividends paid to shareholders of Koninklijke Philips N.V.	-384	-401	453	1	482	412	2	1
Dividends paid to shareholders of non-controlling interests	-2	-3	2	2	2	6	3	2
Net cash provided by (used for) financing activities	55	-1,192	-1,665	483	-2,347	500	-848	-496
Net cash provided by (used for) continuing operations	-	-	-	-	-	-1,160	652	500
Net cash provided by (used for) discontinued operations	1,063	647	-25	-88	3,403	-12	123	-13
Net cash provided by (used for) continuing and discontinued operations	-211	-251	-262	1,856	-986	-1,172	776	487
Effect of exchange rate changes on cash and cash equivalents	-184	-	-2	-55	65	41	-79	45